Pharmacokinetics of dimeric dipeptide mimetic of nerve growth factor GC-2 in rats. Part 1. Single and multiple intravascular and extravascular administration. Testing the hypothesis of linearity of pharmacokinetics

The pharmacokinetics of dimeric dipeptide mimetic of nerve growth factor GC-2 in the rat blood plasma after different routes of administration was studied. The drug was administered at dose of 150 mg/kg by single and repeatedly. After single intravenous and intraperitoneal injection, GC-2 was detecte...

Full description

Saved in:
Bibliographic Details
Main Authors: O. Yu. Kravtsova, O. G. Gribakina, G. B. Kolyvanov, A. A. Litvin, P. O. Bochkov, P. Yu. Povarnina, V. P. Zherdev
Format: Article
Language:Russian
Published: LLC “Publisher OKI” 2023-11-01
Series:Фармакокинетика и Фармакодинамика
Subjects:
Online Access:https://www.pharmacokinetica.ru/jour/article/view/377
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849344902533480448
author O. Yu. Kravtsova
O. G. Gribakina
G. B. Kolyvanov
A. A. Litvin
P. O. Bochkov
P. Yu. Povarnina
V. P. Zherdev
author_facet O. Yu. Kravtsova
O. G. Gribakina
G. B. Kolyvanov
A. A. Litvin
P. O. Bochkov
P. Yu. Povarnina
V. P. Zherdev
author_sort O. Yu. Kravtsova
collection DOAJ
description The pharmacokinetics of dimeric dipeptide mimetic of nerve growth factor GC-2 in the rat blood plasma after different routes of administration was studied. The drug was administered at dose of 150 mg/kg by single and repeatedly. After single intravenous and intraperitoneal injection, GC-2 was detected for 2 h, its half-life was 0.4 h. GC-2 absolute bioavailability after single intraperitoneal injection was 84.62 %, that indicates the prospect of development its injectable (intramuscularly) dosage form. After 4-fold (1.5 h dosing interval) intraperitoneal injection dose-independent pharmacokinetic parameters of GC-2 practically do not change compared to single administration. This indicates that GC-2 is not accumulated in the body of rats. The hypothesis of the linearity of the pharmacokinetics of GC-2 in the rats blood plasma after single intraperitoneal administration at doses of 50, 100 and 150 mg/kg was tested. It was found that the kinetics of GC-2 in the rat blood plasma is linea.
format Article
id doaj-art-e8c497f291f7473f9c19ee94ffb123e4
institution Kabale University
issn 2587-7836
2686-8830
language Russian
publishDate 2023-11-01
publisher LLC “Publisher OKI”
record_format Article
series Фармакокинетика и Фармакодинамика
spelling doaj-art-e8c497f291f7473f9c19ee94ffb123e42025-08-20T03:42:33ZrusLLC “Publisher OKI”Фармакокинетика и Фармакодинамика2587-78362686-88302023-11-0103121810.37489/2587-7836-2023-3-12-18340Pharmacokinetics of dimeric dipeptide mimetic of nerve growth factor GC-2 in rats. Part 1. Single and multiple intravascular and extravascular administration. Testing the hypothesis of linearity of pharmacokineticsO. Yu. Kravtsova0O. G. Gribakina1G. B. Kolyvanov2A. A. Litvin3P. O. Bochkov4P. Yu. Povarnina5V. P. Zherdev6FSBI “Research Zakusov Institue of Pharmacology”FSBI “Research Zakusov Institue of Pharmacology”FSBI “Research Zakusov Institue of Pharmacology”FSBI “Research Zakusov Institue of Pharmacology”FSBI “Research Zakusov Institue of Pharmacology”FSBI “Research Zakusov Institue of Pharmacology”FSBI “Research Zakusov Institue of Pharmacology”The pharmacokinetics of dimeric dipeptide mimetic of nerve growth factor GC-2 in the rat blood plasma after different routes of administration was studied. The drug was administered at dose of 150 mg/kg by single and repeatedly. After single intravenous and intraperitoneal injection, GC-2 was detected for 2 h, its half-life was 0.4 h. GC-2 absolute bioavailability after single intraperitoneal injection was 84.62 %, that indicates the prospect of development its injectable (intramuscularly) dosage form. After 4-fold (1.5 h dosing interval) intraperitoneal injection dose-independent pharmacokinetic parameters of GC-2 practically do not change compared to single administration. This indicates that GC-2 is not accumulated in the body of rats. The hypothesis of the linearity of the pharmacokinetics of GC-2 in the rats blood plasma after single intraperitoneal administration at doses of 50, 100 and 150 mg/kg was tested. It was found that the kinetics of GC-2 in the rat blood plasma is linea.https://www.pharmacokinetica.ru/jour/article/view/377nerve growth factordimeric dipeptide mimetic gk-2preclinical pharmacokineticsabsolute bioavailabilitylinearity of kinetics
spellingShingle O. Yu. Kravtsova
O. G. Gribakina
G. B. Kolyvanov
A. A. Litvin
P. O. Bochkov
P. Yu. Povarnina
V. P. Zherdev
Pharmacokinetics of dimeric dipeptide mimetic of nerve growth factor GC-2 in rats. Part 1. Single and multiple intravascular and extravascular administration. Testing the hypothesis of linearity of pharmacokinetics
Фармакокинетика и Фармакодинамика
nerve growth factor
dimeric dipeptide mimetic gk-2
preclinical pharmacokinetics
absolute bioavailability
linearity of kinetics
title Pharmacokinetics of dimeric dipeptide mimetic of nerve growth factor GC-2 in rats. Part 1. Single and multiple intravascular and extravascular administration. Testing the hypothesis of linearity of pharmacokinetics
title_full Pharmacokinetics of dimeric dipeptide mimetic of nerve growth factor GC-2 in rats. Part 1. Single and multiple intravascular and extravascular administration. Testing the hypothesis of linearity of pharmacokinetics
title_fullStr Pharmacokinetics of dimeric dipeptide mimetic of nerve growth factor GC-2 in rats. Part 1. Single and multiple intravascular and extravascular administration. Testing the hypothesis of linearity of pharmacokinetics
title_full_unstemmed Pharmacokinetics of dimeric dipeptide mimetic of nerve growth factor GC-2 in rats. Part 1. Single and multiple intravascular and extravascular administration. Testing the hypothesis of linearity of pharmacokinetics
title_short Pharmacokinetics of dimeric dipeptide mimetic of nerve growth factor GC-2 in rats. Part 1. Single and multiple intravascular and extravascular administration. Testing the hypothesis of linearity of pharmacokinetics
title_sort pharmacokinetics of dimeric dipeptide mimetic of nerve growth factor gc 2 in rats part 1 single and multiple intravascular and extravascular administration testing the hypothesis of linearity of pharmacokinetics
topic nerve growth factor
dimeric dipeptide mimetic gk-2
preclinical pharmacokinetics
absolute bioavailability
linearity of kinetics
url https://www.pharmacokinetica.ru/jour/article/view/377
work_keys_str_mv AT oyukravtsova pharmacokineticsofdimericdipeptidemimeticofnervegrowthfactorgc2inratspart1singleandmultipleintravascularandextravascularadministrationtestingthehypothesisoflinearityofpharmacokinetics
AT oggribakina pharmacokineticsofdimericdipeptidemimeticofnervegrowthfactorgc2inratspart1singleandmultipleintravascularandextravascularadministrationtestingthehypothesisoflinearityofpharmacokinetics
AT gbkolyvanov pharmacokineticsofdimericdipeptidemimeticofnervegrowthfactorgc2inratspart1singleandmultipleintravascularandextravascularadministrationtestingthehypothesisoflinearityofpharmacokinetics
AT aalitvin pharmacokineticsofdimericdipeptidemimeticofnervegrowthfactorgc2inratspart1singleandmultipleintravascularandextravascularadministrationtestingthehypothesisoflinearityofpharmacokinetics
AT pobochkov pharmacokineticsofdimericdipeptidemimeticofnervegrowthfactorgc2inratspart1singleandmultipleintravascularandextravascularadministrationtestingthehypothesisoflinearityofpharmacokinetics
AT pyupovarnina pharmacokineticsofdimericdipeptidemimeticofnervegrowthfactorgc2inratspart1singleandmultipleintravascularandextravascularadministrationtestingthehypothesisoflinearityofpharmacokinetics
AT vpzherdev pharmacokineticsofdimericdipeptidemimeticofnervegrowthfactorgc2inratspart1singleandmultipleintravascularandextravascularadministrationtestingthehypothesisoflinearityofpharmacokinetics